Cite
Pre‐clinical evaluation of APrevent® VOIS for unilateral vocal fold paralysis medialization.
MLA
Ho, Guan‐Min, et al. “Pre‐clinical Evaluation of APrevent® VOIS for Unilateral Vocal Fold Paralysis Medialization.” Laryngoscope Investigative Otolaryngology, vol. 8, no. 3, June 2023, pp. 712–19. EBSCOhost, https://doi.org/10.1002/lio2.1059.
APA
Ho, G., Rast, J., Hsieh, L., Böttcher, A., Meng, S., Reissig, L. F., Tzou, C., Hess, M. M., Schneider, S. B., Jiang, J., Lai, Y., Yuan, S., Wang, Y., Geyer, S. H., & Weninger, W. J. (2023). Pre‐clinical evaluation of APrevent® VOIS for unilateral vocal fold paralysis medialization. Laryngoscope Investigative Otolaryngology, 8(3), 712–719. https://doi.org/10.1002/lio2.1059
Chicago
Ho, Guan‐Min, Jasmin Rast, Li‐Chun Hsieh, Arne Böttcher, Stefan Meng, Lukas F. Reissig, Chieh‐Han Tzou, et al. 2023. “Pre‐clinical Evaluation of APrevent® VOIS for Unilateral Vocal Fold Paralysis Medialization.” Laryngoscope Investigative Otolaryngology 8 (3): 712–19. doi:10.1002/lio2.1059.